MWNA
CELG

Marshall Wace North America’s Celgene Corp CELG Stock Holding History

Marshall Wace North America’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,116
Closed -$1M – 1776
2019
Q3 		$1M Sell
10,116
-88,082
-90% -$8.37M 0.01% 690
2019
Q2 		$9.08M Buy
98,198
+16,262
+20% +$1.54M 0.06% 257
2019
Q1 		$7.73M Buy
81,936
+44,184
+117% +$3.86M 0.05% 246
2018
Q4 		$2.42M Buy
37,752
+29,485
+357% +$2.18M 0.02% 394
2018
Q3 		$739K Sell
8,267
-155,660
-95% -$13.8M 0.01% 652
2018
Q2 		$13M Sell
163,927
-91,545
-36% -$7.6M 0.07% 277
2018
Q1 		$22.8M Buy
255,472
+238,894
+1,441% +$22.9M 0.11% 209
2017
Q4 		$1.73M Sell
16,578
-239,251
-94% -$27M 0.01% 870
2017
Q3 		$37.4M Buy
255,829
+76,842
+43% +$10.5M 0.24% 107
2017
Q2 		$23.3M Buy
178,987
+140,116
+360% +$17.2M 0.17% 153
2017
Q1 		$4.82M Buy
+38,871
New +$4.65M 0.04% 400
2013
Q4 		$6.22M Buy
+73,606
New +$5.82M 0.13% 171

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Marshall Wace North America's CELG Position: Q4 2019 in Review

Marshall Wace North America sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 10,116 shares — an estimated $1M sold.

Marshall Wace North America first reported a position in CELG in Q4 2013 and held it in 12 quarters. The position peaked at $37.4M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Marshall Wace North America reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Marshall Wace North America sold 10,116 Celgene Corp shares in Q4 2019, an estimated $1M.
  • Marshall Wace North America first reported a position in Celgene Corp in Q4 2013 and held it in 12 quarters.
  • Marshall Wace North America's Celgene Corp position peaked at $37.4M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.